Greg Wolgamot

433 total citations
11 papers, 335 citations indexed

About

Greg Wolgamot is a scholar working on Molecular Biology, Genetics and Virology. According to data from OpenAlex, Greg Wolgamot has authored 11 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Genetics and 3 papers in Virology. Recurrent topics in Greg Wolgamot's work include Virus-based gene therapy research (5 papers), CRISPR and Genetic Engineering (4 papers) and HIV Research and Treatment (3 papers). Greg Wolgamot is often cited by papers focused on Virus-based gene therapy research (5 papers), CRISPR and Genetic Engineering (4 papers) and HIV Research and Treatment (3 papers). Greg Wolgamot collaborates with scholars based in United States. Greg Wolgamot's co-authors include A. Dusty Miller, C. Halbert, Ian E. Alexander, Lynn Bonham, Zsolt B. Argényi, Thomas Reynolds, Hans‐Peter Kiem, John E. Olerud, John E.J. Rasko and Ning Li and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Virology and Dermatology.

In The Last Decade

Greg Wolgamot

11 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Greg Wolgamot United States 10 199 165 59 55 49 11 335
Seham M. Rabadi United States 12 135 0.7× 264 1.6× 45 0.8× 29 0.5× 27 0.6× 12 383
Emily Lowe United States 8 61 0.3× 143 0.9× 171 2.9× 46 0.8× 30 0.6× 13 362
Nicholas D. Weber United States 10 155 0.8× 310 1.9× 15 0.3× 39 0.7× 144 2.9× 12 450
Vivienne B. Gibson United Kingdom 8 77 0.4× 99 0.6× 304 5.2× 9 0.2× 42 0.9× 9 476
Cristina Ciurli Canada 8 39 0.2× 46 0.3× 226 3.8× 77 1.4× 79 1.6× 8 389
Jacqueline Surls United States 6 72 0.4× 45 0.3× 226 3.8× 32 0.6× 40 0.8× 8 321
Sabine Siegemund Germany 11 30 0.2× 79 0.5× 177 3.0× 29 0.5× 85 1.7× 14 342
Aekkachai Puseenam Thailand 9 43 0.2× 144 0.9× 108 1.8× 12 0.2× 275 5.6× 15 506
Stacey Cranert United States 8 40 0.2× 74 0.4× 186 3.2× 18 0.3× 33 0.7× 15 322
Kaley Tash United States 3 47 0.2× 71 0.4× 459 7.8× 51 0.9× 22 0.4× 5 603

Countries citing papers authored by Greg Wolgamot

Since Specialization
Citations

This map shows the geographic impact of Greg Wolgamot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Wolgamot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Wolgamot more than expected).

Fields of papers citing papers by Greg Wolgamot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Greg Wolgamot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Wolgamot. The network helps show where Greg Wolgamot may publish in the future.

Co-authorship network of co-authors of Greg Wolgamot

This figure shows the co-authorship network connecting the top 25 collaborators of Greg Wolgamot. A scholar is included among the top collaborators of Greg Wolgamot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Greg Wolgamot. Greg Wolgamot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Kaufman, Cary S., et al.. (2015). Clinical use of a three-dimensional tissue marker to target postlumpectomy radiation.. Journal of Clinical Oncology. 33(28_suppl). 53–53. 1 indexed citations
2.
Robles, David T., et al.. (2008). Severe Drug Hypersensitivity Reaction in a Young Woman Treated with Doxycycline. Dermatology. 217(1). 23–26. 19 indexed citations
3.
Li, Ning, Greg Wolgamot, & Zsolt B. Argényi. (2007). Primary cutaneous neuroendocrine cell carcinoma (Merkel cell carcinoma) with prominent microcystic features, mimicking eccrine carcinoma. Journal of Cutaneous Pathology. 34(5). 410–414. 12 indexed citations
4.
Wolgamot, Greg, et al.. (2007). Unique Histopathologic Findings in a Patient With Adult-Onset Still Disease. American Journal of Dermatopathology. 29(2). 194–196. 27 indexed citations
5.
Wolgamot, Greg & A. Dusty Miller. (1999). Replication of Mus dunni Endogenous Retrovirus Depends on Promoter Activation Followed by Enhancer Multimerization. Journal of Virology. 73(12). 9803–9809. 19 indexed citations
6.
Wolgamot, Greg, John E.J. Rasko, & A. Dusty Miller. (1998). Retrovirus Packaging Cells Expressing the Mus dunni Endogenous Virus Envelope Facilitate Transduction of CHO and Primary Hematopoietic Cells. Journal of Virology. 72(12). 10242–10245. 11 indexed citations
7.
Wolgamot, Greg, Lynn Bonham, & A. Dusty Miller. (1998). Sequence Analysis of Mus dunni Endogenous Virus Reveals a Hybrid VL30/Gibbon Ape Leukemia Virus-Like Structure and a Distinct Envelope. Journal of Virology. 72(9). 7459–7466. 29 indexed citations
8.
Miller, A. Dusty & Greg Wolgamot. (1997). Murine retroviruses use at least six different receptors for entry into Mus dunni cells. Journal of Virology. 71(6). 4531–4535. 41 indexed citations
9.
Bonham, Lynn, Greg Wolgamot, & A. Dusty Miller. (1997). Molecular cloning of Mus dunni endogenous virus: an unusual retrovirus in a new murine viral interference group with a wide host range. Journal of Virology. 71(6). 4663–4670. 24 indexed citations
10.
Miller, A. Dusty, et al.. (1996). A novel murine retrovirus identified during testing for helper virus in human gene transfer trials. Journal of Virology. 70(3). 1804–1809. 37 indexed citations
11.
Halbert, C., Ian E. Alexander, Greg Wolgamot, & A. Dusty Miller. (1995). Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells. Journal of Virology. 69(3). 1473–1479. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026